Correlation Between Exxon and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Exxon and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exxon and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exxon Mobil Corp and Cannara Biotech, you can compare the effects of market volatilities on Exxon and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exxon with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exxon and Cannara Biotech.

Diversification Opportunities for Exxon and Cannara Biotech

-0.52

Correlation Coefficient

Exxon  Cannara Biotech

Excellent diversification

The 3 months correlation between Exxon and Cannara is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Exxon Mobil Corp and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Exxon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exxon Mobil Corp are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Exxon i.e., Exxon and Cannara Biotech go up and down completely randomly.

Pair Corralation between Exxon and Cannara Biotech

Considering the 90-day investment horizon Exxon Mobil Corp is expected to generate 0.31 times more return on investment than Cannara Biotech. However, Exxon Mobil Corp is 3.21 times less risky than Cannara Biotech. It trades about 0.04 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.0 per unit of risk. If you would invest  9,829  in Exxon Mobil Corp on September 12, 2024 and sell it today you would earn a total of  1,438  from holding Exxon Mobil Corp or generate 14.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Exxon Mobil Corp  vs.  Cannara Biotech

Exxon Mobil Corp

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Exxon Mobil Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Exxon is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Cannara Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Exxon and Cannara Biotech

The main advantage of trading using opposite Exxon and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exxon position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Exxon Mobil Corp and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.